What's breaking now, across thousands of outlets.
Key PointsBristol Myers Squibb maintains a robust specialized drug portfolio and generates strong free cash flow to support its operations.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Key PointsNebius stock has jumped impressively so far in 2026, and I won't be surprised to see it head higher due to its terrific prospects.
The three companies will test on-chain real-time settlement for tokenised money market funds using ringgit-pegged stablecoin.
The three companies will test on-chain real-time settlement for tokenised money market funds using ringgit-pegged stablecoin.
Both face patent cliffs and pay generous dividends, but only one of them can tell you where its next wave of growth is coming from.
The CFTC has been extremely busy ever since the Clarity Act failed its vote, and it appears they’re ready to accelerate.
“We don’t think the dollar will knock it out of the park,” says Daragh Maher, senior FX strategist at HSBC, as he discusses the “ambiguous relationship” he sees between the US dollar and Treasury…
